Sunitinib malate

Product Name:Sunitinib malate

Another Name: SUNITINIB MALEATE; 1H-Pyrrole-3-carboxamide, N-(2-(diethylamino)ethyl)-5-((Z)- (5-fluoro-1,2-dihydro-2-oxo-3H-indol-3-ylidene)methyl)-2,4- dimethyl-, (2S)-hydroxybutanedioate (1:1); Butanedioic acid, hydroxy-, (2S)-, compd. with N-(2- (diethylamino)ethyl)-5-((Z)-(5-fluoro-1,2-dihydro-2-oxo-3H- indol-3-ylidene)methyl)-2,4-dimethyl-1H-pyrrole-3- carboxamide (1:1)

Molecular Formula:C22H27FN4O2.C4H6O5

Molecular Weight:532.56

CAS No.:341031-54-7

Boiling Point:572.1 °C at 760 mmHg

Flash Point:299.8 °C

Application

This is a new multi-targeted treatment of tumors of the oral drug. Sunitinib is the primary development goal for the treatment, does not respond to standard therapy or can not tolerate the gastrointestinal stromal tumor and metastatic renal cell carcinoma of. Sunitinib can selectively target certain protein receptors, which are thought to play a role like a molecular switch in the process of tumor growth.

SupplyAbility

100 Kilogram/Kilograms per Month

Packaging & Delivery

1kg/ Aluminum foil bag;25kg/ DRUM,according to customers' requirements

Port : any port in China

Lead Time :

Shipped in 5 days after payment